external-file_edited (1)_edited_edited_edited_edited.png

Hello.

Welcome to BioFocus.
Explore the latest updates from the life science industry.

London Biotechnology Show_Register Now.png

HEALTH

Collaborating Across Sectors to Eliminate Cervical Cancer

Uniting innovation, equity, and cross-sector collaboration to scale prevention, expand access, and turn cervical cancer into the first cancer eliminated worldwide.

Featured Articles.

BIOTECH

The Future of Medicine Is In Your DNA

PHARMA

Inside Nxera Pharma’s Next-Generation Biopharma Model

BIOPROCESSING

FUJIFILM Biotechnologies Launches UK’s Largest Single-Use Biomanufacturing Facility

BIOTECH

Basecamp Research Launches the Trillion Gene Atlas

BIOTECH

Antiverse Targets Drug Discovery's "Undruggable" Frontier with AI-Driven Antibodies

HEALTH

Killing Mosquitoes With the Smell of Flowers

PHARMA

Pharma & Biotech Quality Summit 2026

SUSTAINABILITY

Engineering Crops From the Inside Out

BIOTECH

PRISM ALS Sets Out to Improve ALS/MND Drug Discovery

Latest News.

27th April, 2026

02. LEO Pharma strengthens psoriasis portfolio in China with NMPA approval of Enstilar®

NMPA approval of Enstilar® marks a key expansion for LEO Pharma in China, bringing a widely used topical psoriasis treatment to an estimated 6.5 million patients amid growing demand for innovative dermatology care.

21st April, 2026

03. Atelerix Launches STORganoid: Cryo-Free Ambient-Temperature Preservation for Organoids and Spheroids

Atelerix Launches STORganoid: Cryo-Free Ambient-Temperature Preservation for Organoids and Spheroids.

14th April, 2026

04. Andelyn Biosciences and Evolyra Therapeutics Join Forces to Advance Gene Therapies for Limb-Girdle Muscular Dystrophy

A new CDMO partnership aims to bring clinical-grade AAV gene therapies to patients with LGMD types 2C and 2D, with an IND filing targeted for the second half of 2026

28th April, 2026

01. AviadoBio Bets on Blood-Brain Barrier Technology in Push for One-Time Alzheimer's Treatment

A licensing deal with Apertura Gene Therapy gives the London-based biotech a clinically validated delivery system to pair with its gene-silencing platform, but the hard work is still ahead.